These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27308948)

  • 1. Faster drug approval: challenges for safety.
    Preziosi P
    Expert Opin Drug Saf; 2016 Sep; 15(9):1205-18. PubMed ID: 27308948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatives to placebo-controlled trials.
    Streiner DL
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S37-41. PubMed ID: 17469680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer.
    Kesselheim AS; Myers JA; Avorn J
    JAMA; 2011 Jun; 305(22):2320-6. PubMed ID: 21642684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drugs and indications in 2013: little real progress but regulatory authorities take some positive steps.
    Prescrire Int; 2014 Apr; 23(148):107-10. PubMed ID: 24860905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated approval of oncology products: a decade of experience.
    Dagher R; Johnson J; Williams G; Keegan P; Pazdur R
    J Natl Cancer Inst; 2004 Oct; 96(20):1500-9. PubMed ID: 15494600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug safety assessment in clinical trials: methodological challenges and opportunities.
    Singh S; Loke YK
    Trials; 2012 Aug; 13():138. PubMed ID: 22906139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated approval of oncology products: the food and drug administration experience.
    Johnson JR; Ning YM; Farrell A; Justice R; Keegan P; Pazdur R
    J Natl Cancer Inst; 2011 Apr; 103(8):636-44. PubMed ID: 21422403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
    Hammad TA; Pinheiro SP; Neyarapally GA
    Clin Trials; 2011 Oct; 8(5):559-70. PubMed ID: 21878445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Drug Trials: The Path to the Patient.
    Diez Pascual C
    Methods Mol Biol; 2021; 2296():411-421. PubMed ID: 33977462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive methods: telling "the rest of the story".
    Emerson SS; Fleming TR
    J Biopharm Stat; 2010 Nov; 20(6):1150-65. PubMed ID: 21058111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Real-World Data to Extrapolate Evidence From Randomized Controlled Trials.
    Wang SV; Schneeweiss S; Gagne JJ; Evers T; Gerlinger C; Desai R; Najafzadeh M
    Clin Pharmacol Ther; 2019 May; 105(5):1156-1163. PubMed ID: 30107034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.
    Hammad TA; Neyarapally GA; Pinheiro SP; Iyasu S; Rochester G; Dal Pan G
    Clin Trials; 2013; 10(3):389-97. PubMed ID: 23508987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging blinded and unblinded analysis for ongoing safety monitoring and evaluation.
    Lin LA; Zhan Y; Li H; Yuan SS; Ball G; Wang W
    Contemp Clin Trials; 2019 Aug; 83():81-87. PubMed ID: 31260790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule.
    Fed Regist; 1992 Dec; 57(239):58942-60. PubMed ID: 10123232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007.
    Sridhara R; Johnson JR; Justice R; Keegan P; Chakravarty A; Pazdur R
    J Natl Cancer Inst; 2010 Feb; 102(4):230-43. PubMed ID: 20118413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.